| Literature DB >> 29955625 |
Kebashni Thandrayen1, John M Pettifor2.
Abstract
The etiology and pathogenesis of nutritional rickets are becoming progressively clearer. Vitamin D deficiency has generally been considered the major or only player in the pathogenesis of nutritional rickets. However, recent research into calcium deficiency has now provided clinicians with reasons to investigate and manage patients with nutritional rickets more appropriately. The important question when assessing cases of nutritional rickets is: "Is it calcium or vitamin D deficiency or both that play a major role in the pathogenesis of the disease?" The case presentation in this review highlights the risk factors, clinical presentation and pathophysiology of nutritional rickets in a young South African black child from a semi-urban area in Johannesburg, a city with abundant sunshine throughout the year.Entities:
Keywords: 1,25 dihydroxyvitamin D; Dietary calcium; Nutritional rickets; Vitamin D
Year: 2018 PMID: 29955625 PMCID: PMC6019962 DOI: 10.1016/j.bonr.2018.01.005
Source DB: PubMed Journal: Bone Rep ISSN: 2352-1872
Fig. 1The index patient presented with genu valgus deformities of the lower limbs at the age of 4 years.
Fig. 2A and B: X-ray of right wrist (AP and lateral views) showing sclerotic bands of healing at the distal metaphyses and possible healed distal radius fracture (evidenced by remodeling defect (tubulation defect) of the distal radius).
Fig. 3Radiological findings at the knees showing slight increased width of the growth plate at distal ends of right and left femurs.
Fig. 4Bowing of right femur and possibly an old healed fracture at the distal midshaft femur with coarsened trabeculae and osteopenia.
Biochemistry and treatment administered to patient over the first 12 months.
| Clinic visits/follow-ups | Initial presentation | 3 month follow-up | 7–8 month follow-up | 10 month follow-up |
|---|---|---|---|---|
| Calcium (mmol/L) | 2.25 | 2.6 | 2.3 | |
| Phosphate (mmol/L) | 1.45 | |||
| Alkaline phosphatase (U/L) (N < 350 IU/L) | 363 | |||
| Parathyroid hormone (N = 1.6–6.9 pmol/L) | 4 | 6 | 6.1 | |
| 25 hydroxyvitamin D (nmol/L) | 49.0 | |||
| 1.25 dihydroxyvitamin D (N = 43–168 pmol/L) | ||||
| Urine calcium/creatinine ratio (mmol/mmol) | 0.14 | |||
| Vitamin D (calciferol) | 5000 IU | 2500 IU | – | – |
| Calcium carbonate | 500 mg (despite 1000 mg being prescribed) | 1000 mg | 1000 mg | 1000 mg |
Age-related changes of the clinical features of rickets.
| Age | Clinical presentation |
|---|---|
| <6 months | Hypocalcaemia |
| >6 months | More common: Chest abnormalities Enlargement of wrists Bony deformities Deformities of the distal radius and ulna Anterior bowing of the tibia |
| >1 year | On weight bearing: Deformities of the lower limbs with initially bowing of the legs But as child gets older, knock-knees and wind-swept deformities |
| At any age | Severe rickets can present with: Fractures Hypotonia Sweating Pain on mobilizing the limbs |
Results in bold are "abnormal results, out of the normal reference range".
Fig. 5Schematic representation of the pathogenesis of vitamin D deficiency and dietary calcium deficiency rickets. + = stimulatory effect; − = suppressive effect; Ca = calcium; iCa = ionized calcium; Pi = inorganic phosphate; PTH = parathyroid hormone; Vit D = vitamin D.
Biochemical differences between vitamin D and calcium deficiency rickets.
| Biochemistry | Vitamin D deficiency rickets | Calcium deficiency rickets |
|---|---|---|
| Calcium | ↓/N | ↓↓/N |
| Phosphate | N/↓ | N/↓ |
| Alkaline phosphatase | ↑↑ | ↑↑ |
| Parathyroid hormone | ↑ | N/↑ |
| 25 hydroxyvitamin D | ↓↓ (<30 nmol/L) | N/borderline low |
| 1.25 dihydroxyvitamin D | N/↓ | ↑↑ |
Treatment doses of vitamin D for nutritional rickets.
| Age | Daily dose for 90 days, IU | Single dose, IU | Maintenance daily dose, IU |
|---|---|---|---|
| <3 months | 2000 | N/A | 400 |
| 3–12 months | 2000 | 50,000 | 400 |
| >12 months to 12 years | 3000–6000 | 150,000 | 600 |
| >12 years | 6000 | 300,000 | 600 |
Abbreviation: N/A, not available. Reassess response to treatment after 3 months as further treatment may be required. Ensure a daily calcium intake of at least 500 mg. For conversion from IU to μg, divide by 40.